Research Reports
- 8/12/2025
2Q25 Included Clinical Strategy Change and Manufacturing Progress
- 8/7/2025
Tecarfarin Clinical Trial To Begin With Modified Design
- 5/9/2025
Cadrenal Reports Tecarfarin Updates With 1Q25 Report
- 3/14/2025
FY2024 Report Reviews A Pivotal Year For Tecarfarin
- 3/5/2025
Development Agreement With Abbott Brings Another Tecarfarin Indication To Clinical Trials
- 11/8/2024
Cadrenal Reports 3Q24 With Tecarfarin Progress Updates
- 8/8/2024
2Q24 Financial Report Confirms Discussions With Abbott For Tecarfarin Development
- 6/5/2024
Data Presentation From LVAD Study Points Out The Need For Tecarfarin
- 5/10/2024
1Q24 Reported With Preparations Continuing For Tecarfarin Phase 3
- 4/12/2024
Tecarfarin Receives Orphan Drug Designation For Second Indication
- 3/13/2024
FY2023 Reported With Continued Progress Toward The Phase 3 Tecarfarin Trial
- 2/1/2024
Peer-Reviewed Journal Reviews Uses of DOAC Drugs, Pointing To The Need For Tecarfarin